Lung abscess as an adverse effect of Risankizumab

Given the lack of notable risk factors for lung abscess, this case suggests a possible association with Risankizumab, which may have contributed to immunosuppression.

Authors

Institutions

Publication Details

Journal
European Clinical Respiratory Journal
Published
2026-01-07
DOI
https://doi.org/10.1080/20018525.2025.2611608
Citations
1
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
36.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lung abscess as an adverse effect of Risankizumab

Tim Lewis, Stuart Jesin, William Pascal, Zarif Kazi et al.
1 citations
European Clinical Respiratory Journal
Pleural and Pulmonary Diseases
36.44
article

Lung abscess as an adverse effect of Risankizumab

Tim Lewis, Stuart Jesin, William Pascal, Zarif Kazi, Thai Donenfeld, Kevin Clements, Samir Ghimire
article en
1 citations

Abstract

Given the lack of notable risk factors for lung abscess, this case suggests a possible association with Risankizumab, which may have contributed to immunosuppression.

European Clinical Respiratory JournalVol. 13(1)
Maimonides Medical Center (US)
Good health and well-being
Openalex Percentile: Top 2%
Pleural and Pulmonary Diseases
36.44
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lung abscess as an adverse effect of Risankizumab — Tim Lewis, Stuart Jesin, et al. · European Clinical Respiratory Journal (2026) | TGRS Research Map | TGRS